RaySearch Laboratories AB (publ) today announces the release of RayCare v2026, the latest version of its oncology information system. The new release introduces enhanced workflow visualization, improved interoperability, strengthened data security, and new capabilities for coordination, further supporting efficient and integrated cancer care.

Workflow and coordination improvements
RayCare v2026 introduces a new workflow timeline, providing a timeline-based visualization of tasks directly within the patient chart. This new view presents clinical activities in a clearer and more intuitive way, with a better overview of ongoing and upcoming tasks. Improvements to several workspaces, including the image viewer and scheduling interfaces, enhance usability and provide more efficient access to information and tools for daily clinical work.

Improved data security and interoperability
RayCare v2026 builds on an already strong security foundation by introducing encrypted DICOM communication between RayCare and RayStation, and extending support to treatment delivery devices that implement DICOM encryption, supporting evolving cybersecurity requirements across connected systems.

Platform development and automation
RayCare v2026 is designed to support ongoing expansion of interoperability and integration across the radiotherapy ecosystem. The release also introduces a standardized interface for treatment delivery devices. This enables integration with a broader range of systems, as vendors implement the same support, providing a scalable foundation for future connectivity and more flexible clinical environments.

The release includes improvements to scripting capabilities and system configuration, supporting automation of workflows and enabling clinics to adapt the system to their specific needs.

“With RayCare v2026, we continue to advance our vision of a fully integrated and comprehensive oncology information system,” says Johan Löf, founder and CEO of RaySearch. “The new capabilities improve usability, connectivity, and security across clinical workflows, helping cancer centers deliver coordinated, efficient, and patient-centered care.”

To learn more about RayCare v2026 and explore the full set of new features, please visit the RayCare v2026 release page: https://www.raysearchlabs.com/raycare-v2026/

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB 
Tel: +46 (0) 8 510 530 00 

Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB 
Tel: +46 (0) 708 807 173
ir@raysearchlabs.com

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure, and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,200 clinics in 51 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.

About RayCare
RayCare is an oncology information system designed to support the full workflow of cancer care. It integrates scheduling, clinical workflows, treatment management and data handling into a single system, enabling coordinated and efficient care delivery across the treatment process.

Learn more about us on:
LinkedIn
YouTube

*Subject to regulatory clearance in some markets. Functionality available may vary depending on market authorization.

Attachments
RaySearch releases RayCare v2026